InvestorsHub Logo
Followers 205
Posts 9190
Boards Moderated 1
Alias Born 11/26/2010

Re: KeepItRealistic post# 33050

Saturday, 10/17/2020 9:14:44 AM

Saturday, October 17, 2020 9:14:44 AM

Post# of 35961
Ridgeway Therapeutics owns 65mil shares out of 120mil shares in $NSPX float. Ridgeway Therapeutics CEO: Dr. Hislop served as Vice President of Clinical Development at CV Therapeutics where he developed and filed an NDA for Ranexa®? for angina. CV Therapeutics was acquired by $GILD for $1.4 billion.

https://theorg.com/org/eiger-biopharmaceuticals/team/colin-hislop

https://www.linkedin.com/in/colin-hislop-m-b-b-s-b716905

$NSPX, like $GILD Remdesivir utilizes similar targeting of adenosine for a novel COVID-19 treatment.

http://web.archive.org/web/20200427204401/https://www.marketwatch.com/press-release/these-companies-are-high-potential-game-changers-for-covid-19-treatments-vaccines-2020-03-27